NTN BUZZTIME INC License Agreements

6 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Exclusive License Agreement, dated November 22, 2022, by and among Eterna Therapeutics Inc., Brooklyn Immunotherapeutics LLC, Novellus Therapeutics Limited and...
License Agreements
NTN BUZZTIME INC
Biotechnology
2022
Amended and Restated Exclusive License Agreement, dated November 14, 2023, by and between Factor Bioscience Limited and Eterna Therapeutics Inc
License Agreements
NTN BUZZTIME INC
2023
First Amendment to Exclusive License Agreement, dated as of July 12, 2023, by and between Eterna Therapeutics Inc. and Factor Bioscience Limited
License Agreements
NTN BUZZTIME INC
2023
Exclusive License Agreement, dated February 20, 2023, by and between Factor Bioscience Limited and Eterna Therapeutics Inc
License Agreements
NTN BUZZTIME INC
Biotechnology
NY
2023
Third Amended and Restated Exclusive License Agreement, dated November 1, 2020, by and between Factor Bioscience Limited and Novellus Therapeutics Limited
License Agreements
NTN BUZZTIME INC
Biotechnology
MA
2022
Exclusive License Agreement, dated as of April 26, 2021, between Factor Bioscience Limited, Novellus Therapeutics Limited and Brooklyn ImmunoTherapeutics LLC
License Agreements
NTN BUZZTIME INC
Biotechnology
MA
2021